Abstract
Front Cover In article number 2100770, Dai, Qiu, Liu and co-workers demonstrate the water-soluble benzo[4]helicenium has selective killing effects of renal cell carcinoma through inducing DNA damage. Compared with normal cells, it can more easily enter the tumor cells and further affect the biological functions of DNA because of the rapid mitosis. Benzo[4]helicenium is expected to be a novel drug for the precise therapy of renal cell carcinoma.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
